-

Novanta to Present at Jefferies Global Healthcare Conference on Tuesday, November 18, 2025

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, in London.

About Novanta

Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary technology expertise and competencies in precision medicine and manufacturing, medical solutions, and robotics and automation with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta’s common shares are quoted on Nasdaq under the ticker symbol “NOVT.”

More information about Novanta is available on the Company’s website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or InvestorRelations@novanta.com.

Contacts

Novanta Inc.
Investor Relations:
Ray Nash
(781) 266-5137
InvestorRelations@novanta.com

Industry:

Novanta Inc.

NASDAQ:NOVT
Release Versions
English

Contacts

Novanta Inc.
Investor Relations:
Ray Nash
(781) 266-5137
InvestorRelations@novanta.com

More News From Novanta Inc.

Novanta Inc. Announces Pricing of $550,000,000 Tangible Equity Units Offering

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has priced its previously announced public offering of 11 million of its 6.50% tangible equity units at $50.00 per unit (equal to the stated amount per unit). The transaction is a public offering made by means of a prospectus supplement under Novanta’s effective shelf registration statement. Novanta’s...

Novanta Inc. Announces Offering of Tangible Equity Units

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) ("Novanta" or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has commenced a public offering of 11 million tangible equity units, with an aggregate stated amount of $550.0 million. Each tangible equity unit will have a stated amount of $50.00 and be comprised of a prepaid stock purchase contract and a senior amortizing note due 2028, each issued by Novanta. The...

Novanta Announces Financial Results for the Third Quarter 2025

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2025. Financial Highlights Three Months Ended (In millions, except per share amounts) September 26,   September 27,   2025   2024 GAAP           Revenue $ 247.8     $ 244.4   Operating Income $ 21.8     $ 32.6   Net Income $ 10.7     $ 19.2   Diluted EPS $ 0.30     $ 0.53...
Back to Newsroom